VIVA Biotech Holdings

Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
2,063
Ticker
1873
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Viva Biotech Holdings is a prominent player in the biotechnology sector, primarily engaged in offering contract research organization (CRO) services. The company's core function is to provide integrat...

VIVA Biotech Holdings's GHG Emissions Data Preview

In 2022, VIVA Biotech Holdings completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, VIVA Biotech Holdings has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2022202120202019 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind VIVA Biotech Holdings’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore VIVA Biotech Holdings’s data sources below and access millions more through our Disclosure Search.

a. VIVA Biotech Holdings's ESG Report 2022
a. VIVA Biotech Holdings's ESG Report 2022

Insights into VIVA Biotech Holdings's Operational Emissions

In 2022, the total operational greenhouse gas (GHG) emissions of VIVA Biotech Holdings amounted to 28,888.71 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2021, the total operational greenhouse gas (GHG) emissions of VIVA Biotech Holdings decreased by 22.88%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

VIVA Biotech Holdings's Scope 1 Emissions Over Time

2021202204008001.2 k1.6 ktCO2e+47%
  • Total Scope 1
  • Year-over-Year Change

What are VIVA Biotech Holdings's Scope 1 emissions?

In 2022, the total Scope 1 emissions of VIVA Biotech Holdings were 1,404.35 metric tons of CO₂ equivalent (tCO₂e). a

Compared to the previous year (2021), VIVA Biotech Holdings's Scope 1 emissions increased by 46.58%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are VIVA Biotech Holdings's Scope 2 emissions?

In 2022, VIVA Biotech Holdings reported Scope 2 greenhouse gas (GHG) emissions of 27,484.36 tCO₂e without specifying the calculation method. a

Has VIVA Biotech Holdings reduced its Scope 2 emissions over time?

Compared to the previous year (2021), VIVA Biotech Holdings's Scope 2 emissions (Unspecified Calculation Method) fell by 24.7% in 2022, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a

What methodology does VIVA Biotech Holdings use for Scope 2 reporting?

In 2022, VIVA Biotech Holdings reported its Scope 2 emissions using an unspecified methodology. a

VIVA Biotech Holdings's Scope 2 Emissions Over Time

2021202209.5 k19 k28.5 k38 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into VIVA Biotech Holdings’s GHG Emissions Intensity Compared to Industry Peers

In 2022, VIVA Biotech Holdings reported Scope 1 greenhouse gas (GHG) emissions of 1,404.35 tCO₂e and total revenues of USD 373 millions. This translates into an emissions intensity of 3.76 tCO₂e per millions USD. a

VIVA Biotech Holdings's Scope 1 Emissions Intensity Compared to Peers

0.5102005,000100,000Scope 1 Emissions (tCO2e)2202002,00020,000Revenues (Millions of USD)AASInnoCare PharmaYear: 2023Scope 1: 20 tCO2eRevenue: $M 104Scope 1 Intensity: 0.19 tCO2e/$MAntengeneYear: 2023Scope 1: 45 tCO2eRevenue: $M 10Scope 1 Intensity: 4.37 tCO2e/$MShanghai Henlius BiotechYear: 2023Scope 1: 6,909 tCO2eRevenue: $M 830Scope 1 Intensity: 8.32 tCO2e/$MRemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MGenscript BiotechYear: 2024Scope 1: 39,377 tCO2eRevenue: $M 4,637Scope 1 Intensity: 8.49 tCO2e/$MAAAscentage PharmaYear: 2023Scope 1: 2,081 tCO2eRevenue: $M 34Scope 1 Intensity: 61.05 tCO2e/$MShanghai Junshi BiosciencesYear: 2024Scope 1: 5,308 tCO2eRevenue: $M 267Scope 1 Intensity: 19.88 tCO2e/$MEverest MedicinesYear: 2023Scope 1: 0 tCO2eRevenue: $M 19Scope 1 Intensity: 0.02 tCO2e/$MInnovent BiologicsYear: 2023Scope 1: 65 tCO2eRevenue: $M 953Scope 1 Intensity: 0.07 tCO2e/$MAkesoYear: 2024Scope 1: 6,408 tCO2eRevenue: $M 318Scope 1 Intensity: 20.17 tCO2e/$MAAAurisco PharmaceuticalYear: 2024Scope 1: 2,731 tCO2eRevenue: $M 202Scope 1 Intensity: 13.51 tCO2e/$MCARsgen Therapeutics HoldingsYear: 2021Scope 1: 117 tCO2eRevenue: $M 4Scope 1 Intensity: 28.91 tCO2e/$MZai LabYear: 2023Scope 1: 15 tCO2eRevenue: $M 267Scope 1 Intensity: 0.06 tCO2e/$MSSSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 237Scope 1 Intensity: 26.78 tCO2e/$MZhifeiYear: 2023Scope 1: 14,211 tCO2eRevenue: $M 7,446Scope 1 Intensity: 1.91 tCO2e/$MKintor PharmaceuticalYear: 2021Scope 1: 29 tCO2eRevenue: $M 5Scope 1 Intensity: 5.35 tCO2e/$MAscletis PharmaYear: 2023Scope 1: 422 tCO2eRevenue: $M 9Scope 1 Intensity: 48.50 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MJacobio Pharmaceuticals GroupYear: 2023Scope 1: 34 tCO2eRevenue: $M 10Scope 1 Intensity: 3.48 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2023Scope 1: 46,854 tCO2eRevenue: $M 1,101Scope 1 Intensity: 42.55 tCO2e/$MWuXi Biologics (Cayman)Year: 2023Scope 1: 32,687 tCO2eRevenue: $M 2,603Scope 1 Intensity: 12.56 tCO2e/$MAlphamab OncologyYear: 2023Scope 1: 3,970 tCO2eRevenue: $M 34Scope 1 Intensity: 117.90 tCO2e/$MVIVA Biotech HoldingsYear: 2022Scope 1: 1,404 tCO2eRevenue: $M 373Scope 1 Intensity: 3.76 tCO2e/$M

How does VIVA Biotech Holdings's GHG emissions intensity compare to its peers?

In 2022, VIVA Biotech Holdings reported a Scope 1 emissions intensity of 3.76 tCO₂e per millions USD. Compared to the peer group median of 9.75 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does VIVA Biotech Holdings rank on GHG emissions intensity within its industry?

In 2022, VIVA Biotech Holdings ranked 8 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

VIVA Biotech Holdings is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to VIVA Biotech Holdings's GHG Emissions Dataset?
Sign Up